Test Code 2HGA 2-Hydroxyglutaric Acid Chiral Analysis, Quantitative, Random, Urine
Necessary Information
1. Age and sex of patient are required.
2. Biochemical Genetics Patient Information (T602) is recommended, but not required, to be filled out and sent with the specimen to aid in the interpretation of test results.
Specimen Required
Supplies: Urine Tube, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 10 mL
Pediatric: If the collection volume appears insufficient, submit as much specimen as possible in a single container; the laboratory will determine if volume is sufficient for test.
Collection Instructions:
1. Collect a random urine specimen (first morning void preferred)
2. No preservative
Useful For
Determining type of 2-hydroxyglutaric aciduria by chiral analysis of urine
Method Name
Gas Chromatography Mass Spectrometry (GC-MS)
Reporting Name
D-,L- 2-Hydroxyglutaric Acid, QN, USpecimen Type
UrineSpecimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Frozen (preferred) | 416 days | |
Ambient | 14 days | ||
Refrigerated | 14 days |
Reference Values
Age |
D-2-hydroxyglutaric acid (mmol/mol creatinine) |
L-2-hydroxyglutaric acid |
0-11 months |
≤14.11 |
≤17.38 |
12-23 months |
≤13.76 |
≤17.03 |
24-35 months |
≤13.38 |
≤16.63 |
3 years |
≤12.96 |
≤16.18 |
4 years |
≤12.20 |
≤15.35 |
5 years |
≤11.40 |
≤14.44 |
6 years |
≤10.56 |
≤13.46 |
7 years |
≤9.71 |
≤12.43 |
8 years |
≤8.93 |
≤11.44 |
9 years |
≤8.21 |
≤10.50 |
10 years |
≤7.56 |
≤9.66 |
11 years |
≤6.99 |
≤8.94 |
12 years |
≤6.47 |
≤8.33 |
13 years |
≤6.01 |
≤7.83 |
14 years |
≤5.60 |
≤7.44 |
15 years |
≤5.23 |
≤7.14 |
16 years |
≤4.91 |
≤6.93 |
17 years |
≤4.63 |
≤6.78 |
18 years |
≤4.40 |
≤6.69 |
19 years |
≤4.21 |
≤6.63 |
20 years |
≤4.07 |
≤6.60 |
21 years |
≤3.96 |
≤6.59 |
22 years |
≤3.88 |
≤6.58 |
23 years |
≤3.81 |
≤6.56 |
24 years |
≤3.76 |
≤6.54 |
25 years |
≤3.71 |
≤6.50 |
26 years |
≤3.67 |
≤6.44 |
27 years |
≤3.63 |
≤6.37 |
28 years |
≤3.59 |
≤6.27 |
29 years |
≤3.56 |
≤6.15 |
30 years |
≤3.54 |
≤6.02 |
31 years |
≤3.52 |
≤5.87 |
32 years |
≤3.50 |
≤5.72 |
33 years |
≤3.49 |
≤5.57 |
34 years |
≤3.48 |
≤5.41 |
35 years |
≤3.46 |
≤5.26 |
36 years |
≤3.45 |
≤5.13 |
37 years |
≤3.43 |
≤5.00 |
38 years |
≤3.42 |
≤4.88 |
39 years |
≤3.40 |
≤4.78 |
40 years |
≤3.39 |
≤4.70 |
41 years |
≤3.37 |
≤4.62 |
42 years |
≤3.35 |
≤4.55 |
43 years |
≤3.33 |
≤4.50 |
44 years |
≤3.30 |
≤4.44 |
45 years |
≤3.28 |
≤4.40 |
46 years |
≤3.24 |
≤4.35 |
47 years |
≤3.21 |
≤4.31 |
48 years |
≤3.17 |
≤4.27 |
49 years |
≤3.13 |
≤4.23 |
50 years |
≤3.10 |
≤4.19 |
51 years |
≤3.07 |
≤4.16 |
52 years |
≤3.04 |
≤4.12 |
53 years |
≤3.01 |
≤4.10 |
54 years |
≤2.99 |
≤4.07 |
55 years |
≤2.97 |
≤4.04 |
56 years |
≤2.95 |
≤4.01 |
57 years |
≤2.93 |
≤3.98 |
58 years |
≤2.91 |
≤3.94 |
59 years |
≤2.89 |
≤3.91 |
60 years |
≤2.87 |
≤3.87 |
61 years |
≤2.85 |
≤3.84 |
62 years |
≤2.83 |
≤3.80 |
63 years |
≤2.79 |
≤3.78 |
64 years |
≤2.76 |
≤3.75 |
65 years |
≤2.71 |
≤3.73 |
66 years |
≤2.67 |
≤3.72 |
67 years |
≤2.61 |
≤3.71 |
68 years |
≤2.56 |
≤3.69 |
69 years |
≤2.50 |
≤3.68 |
70 years |
≤2.44 |
≤3.66 |
71 years |
≤2.38 |
≤3.64 |
72 years |
≤2.32 |
≤3.61 |
73 years |
≤2.26 |
≤3.56 |
74 years |
≤2.21 |
≤3.50 |
75 years |
≤2.16 |
≤3.43 |
76 years |
≤2.10 |
≤3.35 |
77 years |
≤2.05 |
≤3.26 |
78 years |
≤2.00 |
≤3.17 |
79 years |
≤1.94 |
≤3.08 |
80 years |
≤1.89 |
≤2.99 |
81 years |
≤1.84 |
≤2.91 |
82 years |
≤1.80 |
≤2.84 |
83 years |
≤1.75 |
≤2.78 |
84 years |
≤1.71 |
≤2.73 |
85 years |
≤1.68 |
≤2.69 |
86 years |
≤1.65 |
≤2.67 |
87 years |
≤1.64 |
≤2.65 |
88 years |
≤1.63 |
≤2.64 |
≥89 years |
≤1.62 |
≤2.64 |
Interpretation
The values for the D-2-hydroxyglutaric acid and L-2-hydroxyglutaric acid concentrations are reported. The interpretation of the result must be correlated with clinical and other laboratory findings.
Clinical Reference
1. Kranendijk M, Struys EA, Salomons GS, Van der Knaap MS, Jakobs C. Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis. 2012;35(4):571-587. doi:10.1007/s10545-012-9462-5
2. Muhlhausen C, Salomons GS, Lukacs Z, et al. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment. J Inherit Metab Dis. 2014;37(5):775-781. doi:10.1007/s10545-014-9702-y
3. Struys EA. D-2-Hydroxyglutaric aciduria: unravelling the biochemical pathway and the genetic defect. J Inherit Metab Dis. 2006;29(1):21-29. doi:10.1007/s10545-006-0317-9
4. Perales-Clemente E, Hewitt AL, Studinski AL, et al. Bilateral subdural hematomas and retinal hemorrhages mimicking nonaccidental trauma in a patient with D-2-hydroxyglutaric aciduria. JIMD Rep. 2020;58(1):21-28. doi:10.1002/jmd2.12188
Day(s) Performed
Thursday
Report Available
3 to 9 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83921 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
2HGA | D-,L- 2-Hydroxyglutaric Acid, QN, U | 79297-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
614619 | Interpretation | 79303-4 |
614620 | D-2-Hydroxyglutaric acid | 80100-1 |
614621 | L-2-Hydroxyglutaric acid | 80099-5 |
614622 | Reviewed By | 18771-6 |
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.